Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019

SELL
$19.85 - $22.76 $992 - $1,138
-50 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $872 - $1,076
50 New
50 $1,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.